Skip to content

REVBW

REVELATION BIOSCIENCES, INC.

NASDAQ · Healthcare · Biotechnology · US

$0.01
+5.77%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.00x
Price / sales
—
Price / cash flow
-0.00x

Enterprise value

Enterprise value
-$10.7M
EV / sales
—
EV / EBITDA
0.98x
EV / EBIT
0.95x
Market cap
$34.1K

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026